James M Daly Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James M Daly.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James M Daly. James M Daly is a EVP, Chief Commercial Officer in INCYTE CORP ($INCY) and a Exec. VP & Chief Comm. Officer in INCYTE CORP ($INCY) and a in ACADIA PHARMACEUTICALS INC ($ACAD) and a Director in ACADIA PHARMACEUTICALS INC ($ACAD) and a Director in HALOZYME THERAPEUTICS INC ($GYHT) and a Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and a Director in CHIMERIX INC ($CMRX) and a Director in BELLICUM PHARMACEUTICALS, INC ($BLCM).
Address: EXPERIMENTAL STATION ROUTE 141 & HENRY CLAY ROAD WILMINGTON 19880 DE
Companies in which James M Daly is an Insider
ACADIA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James M Daly: Director
Holdings: 11,250 shares
Current Value: $429,638
Latest Transaction: Jun 25 2020
$ACAD Market Capitalization: $4.67B
$ACAD Previous Close: $38.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BELLICUM PHARMACEUTICALS, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James M Daly: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2020
$BLCM Market Capitalization: $335.83M
$BLCM Previous Close: $12.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CHIMERIX INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James M Daly: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 24 2019
$CMRX Market Capitalization: $255.66M
$CMRX Previous Close: $5.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HALOZYME THERAPEUTICS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James M Daly: Director
Holdings: 26,232 shares
Latest Transaction: May 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of James M Daly: EVP, Chief Commercial Officer, Exec. VP & Chief Comm. Officer
Holdings: 3,521 shares
Current Value: $416,112
Latest Transaction: Jun 25 2015
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MADRIGAL PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James M Daly: Director
Holdings: 0 shares
Latest Transaction: Jun 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James M Daly
Sentiment: All, ACAD, BLCM, CMRX, GYHT, INCY, SNTA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | GYHT | HALOZYME THERAPEUT ... | Daly James M | Director | Grant | A | 0.00 | 5,230 | 0 | 26,232 | 21 K to 26.2 K (+24.90 %) |
| Aug 13 2020 | GYHT | HALOZYME THERAPEUT ... | Daly James M | Director | Sell | S | 29.12 | 34,337 | 999,893 | 31,365 | 65.7 K to 31.4 K (-52.26 %) |
| Jun 25 2020 | ACAD | ACADIA PHARMACEUTI ... | Daly James M | Director | Option Exercise | A | 0.00 | 3,059 | 0 | 3,059 | |
| Jun 25 2020 | ACAD | ACADIA PHARMACEUTI ... | Daly James M | Director | Option Exercise | A | 52.73 | 5,579 | 294,181 | 5,579 | |
| Jun 18 2020 | SNTA | MADRIGAL PHARMACEU ... | Daly James M | Director | Option Exercise | A | 111.06 | 6,000 | 666,360 | 6,000 | |
| Jun 16 2020 | BLCM | BELLICUM PHARMACEU ... | Daly James M | Director | Option Exercise | A | 8.42 | 6,500 | 54,730 | 6,500 | |
| Jun 16 2020 | BLCM | BELLICUM PHARMACEU ... | Daly James M | Director | Option Exercise | A | 8.42 | 6,500 | 54,730 | 6,500 |